Cargando…
Osteosarcoma and Metastasis Associated Bone Degradation—A Tale of Osteoclast and Malignant Cell Cooperativity
Cancer-induced bone degradation is part of the pathological process associated with both primary bone cancers, such as osteosarcoma, and bone metastases originating from, e.g., breast, prostate, and colon carcinomas. Typically, this includes a cancer-dependent hijacking of processes also occurring d...
Autores principales: | Nørregaard, Kirstine Sandal, Jürgensen, Henrik Jessen, Gårdsvoll, Henrik, Engelholm, Lars Henning, Behrendt, Niels, Søe, Kent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8269025/ https://www.ncbi.nlm.nih.gov/pubmed/34202300 http://dx.doi.org/10.3390/ijms22136865 |
Ejemplares similares
-
Tumor cell MT1-MMP is dispensable for osteosarcoma tumor growth, bone degradation and lung metastasis
por: Ingvarsen, Signe Z., et al.
Publicado: (2020) -
The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers
por: Nielsen, Christoffer Fagernæs, et al.
Publicado: (2017) -
The Collagen Receptor uPARAP in Malignant Mesothelioma: A Potential Diagnostic Marker and Therapeutic Target
por: Çakılkaya, Pınar, et al.
Publicado: (2021) -
The collagen receptor uPARAP/Endo180 in tissue degradation and cancer (Review)
por: MELANDER, MARIA C., et al.
Publicado: (2015) -
Immune regulation by fibroblasts in tissue injury depends on uPARAP-mediated uptake of collectins
por: Jürgensen, Henrik J., et al.
Publicado: (2019)